Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How to apply for vascepa's patient assistance?Is allopurinol expensive?The expiration date of the key patent for guselkumab?Is januvia still on the market?Patent expiration eu dabrafenib?
See the DrugPatentWatch profile for cosentyx
The information provided does not include any specific data or guidance about an interaction between Cosentyx (secukinumab) and COVID-19 vaccines. No claims about safety, effectiveness, or contraindications can be confirmed from the supplied material.
No vaccine guidance (including recommendations for people taking Cosentyx) is included in the information provided.
The supplied information does not address vaccine immune response, reduced effectiveness, or added risk for IL-17 inhibitors such as Cosentyx.
If you’re taking Cosentyx and planning a COVID-19 vaccination (or a booster), the most reliable next step is to follow advice from your prescriber or pharmacist, since recommendations depend on your vaccine type, timing, and health conditions. If you share which COVID-19 vaccine you’re asking about (for example, mRNA vs. viral vector) and whether you’re asking about timing relative to your Cosentyx doses, I can tailor the answer to that scenario—within the limits of the available information.
Other Questions About Cosentyx :